Articles by Larry Nold - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Larry Nold

FDA Inspections: Is Your Organization 21 CFR Part 11 Compliant?

Nov 1, 2003

Decoding what FDA means by “narrow interpretation” and “enforcement discretion” goes a long way toward helping you understand the FDA’s latest guidance on 21 CFR Part 11 and making sure your organization is compliant before an inspection.

ADVERTISEMENT

ADVERTISEMENT

Click here